ArticleNature communications2023

The Oncology Biomarker Discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer.

Alexander J Ohnmacht et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.